James N. Topper, Director at NewAmsterdam Pharma Co N.V. (NAMS), bought 3,780 shares at $18.43 ($69K) on 2025-06-24, disclosed to the SEC on 2025-06-26.
Open-market purchase of $69k NAMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.43 | 2,520 | $46K | 66.9% |
| 2 | $18.26 | 1,260 | $23K | 33.1% |
| Total | $18.37 avg | 3,780 | $69K | 100% |
| Filing → |
| NAMS | BUY | 2025-08-13 | $11K | — | Filing → |
| NAMS | BUY | 2025-06-18 | $167K | — | Filing → |
| PHAT | BUY | 2025-05-23 | $15K | — | Filing → |